重组蛋白 HLA-C*03:04 & B2M & KRAS G12D (GADGVGKSAL) Tetramer 人 His Avi产品图
文献支持

重组蛋白 HLA-C*03:04 & B2M & KRAS

G12D (GADGVGKSAL) Tetramer 人 His Avi
收藏
  • ¥9900 - 33000
  • 上海经科
  • 中国
  • JK7661
  • 2026年09月28日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 保存条件:

      -20℃

    • 保质期:

      3 months at -20°C

    • 英文名:

      HLA-C*03:04&B2M&KRAS G12D (GADGVGKSAL) Tetramer, His & Avi, Human

    • 库存:

      现货

    • 供应商:

      上海经科化学科技有限公司

    • 规格:

      100μg/500μg

    规格:100μg产品价格:¥9900.0
    规格:500μg产品价格:¥33000.0
    产品简介
    Species Human
    Protein Construction
    HLA-C*03:04&B2M&KRAS G12D (GADGVGKSAL) Tetramer[Gly25-Thr305 (HLA-C 03:04), Ile21-Met119 (B2M) and GADGVGKSAL peptide]
    Accession # QAV56463.1(HLA-C*03:04)&P61769(B2M)&GADGVGKSAL
    His Avi
    N-term C-term
    Purity > 95% as determined by BisTris PAGE
    Endotoxin Level Less than 1EU per μg by the LAL method.
    Expression System HEK293
    Theoretical Molecular Weight 258 kDa
    Apparent Molecular Weight Due to glycosylation, the protein migrates to 260-265 kDa under Non reducing (N) condition based on Bis-Tris PAGE result.
    Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
    Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
    Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.
    技术背景
    Target Background Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
    Synonyms MHC; KRAS; K-Ras 2; KRAS2; C-K-RAS; CFC2; K-RAS2A; K-RAS2B; K-RAS4A; K-RAS4B; KRAS1; KRAS2; NS; NS3; RASK2; GTPase Kras; KI-RAS; RALD

    产品特点:

    1. 【人源天然序列】采用人源 HLA-C*03:04、B2M 天然氨基酸序列,结合 KRAS G12D GADGVGKSAL 抗原肽,与体内天然 HLA 四聚体结构完全一致,可特异性结合 T 细胞受体2. 【高活性高特异性】可特异性结合对应 T 细胞受体,ED₅₀ < 100 ng/mL(T 细胞结合实验),可被 HLA 特异性抗体识别,适用于 T 细胞筛选、抗原特异性免疫研究3. 【高纯度低内毒素】SDS-PAGE 纯度 > 95%,内毒素 < 0.5 EU/μg(LAL 法),无支原体、细菌、真菌等微生物污染,适配多种科研实验需求4. 【双标签易纯化检测】哺乳动物细胞表达,N 端带 Avi 标签、C 端带 His 标签,可通过 Ni-NTA 亲和层析快速纯化,也可通过 Avi/His 标签抗体进行特异性检测5. 【稳定易保存】蛋白储存液配方优化,未开封 - 80℃可稳定保存 12 个月,-20℃可存 6 个月,避免反复冻融可长期保持蛋白活性6. 【多场景适配】可用于 HLA 蛋白结构与功能研究、KRAS 突变体抗原特异性 T 细胞免疫机制研究、肿瘤免疫治疗研究、细胞培养添加剂、药物筛选、抗体研发等

    HLA-C03:04,B2M,KRAS G12D,HLA 四聚体,人源,人,重组蛋白,重组,高活性,高纯度,低内毒素,His 标签,Avi 标签,细胞培养,免疫细胞,科研实验,哺乳动物细胞表达,Human,HLA-C03:04,B2M,KRAS G12D,Recombinant protein,HLA tetramer,His-tagged,Avi-tagged,High activity,High purity,Low endotoxin,Cell culture,Immune cell,Mammalian expression

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献
    Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥800
    安元生物科技(南京)有限公司
    2026年09月29日询价
    ¥9900
    上海经科化学科技有限公司
    2026年05月21日询价
    ¥3870
    上海优宁维生物科技股份有限公司
    2025年08月27日询价
    ¥5824
    MedChemExpress LLC
    2025年12月05日询价
    文献支持
    重组蛋白 HLA-C*03:04 & B2M & KRAS G12D (GADGVGKSAL) Tetramer 人 His Avi
    ¥9900 - 33000